Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1363467

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1363467

Benign Prostatic Hyperplasia Treatment Devices Market Size, Share & Trends Analysis Report By Treatment, By Procedure, By Product (Resectoscopes, Urology Laser), By End-use, By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Benign Prostatic Hyperplasia Treatment Devices Market Growth & Trends:

The global benign prostatic hyperplasia treatment devices market size is anticipated to reach USD 2.79 billion by 2030, registering at a CAGR of 8.90% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing application of the robotic system used for the benign prostatic hyperplasia (BPH) treatments, enhancements in the aquablation therapy, early disease diagnosis and increasing health awareness among people drive the market growth. Due to the rising prevalence of BPH and the ongoing development of novel therapy alternatives, the BPH treatment device market is anticipated to expand globally.

Aquablation therapy involves the use of a system that combines water and radiofrequency energy. Normally, either local or general anesthesia is used during the surgery. When compared to the open surgical treatments for BPH, aquablation therapy has a number of advantages, including less bleeding and a shorter catheterization period. For instance, in April 2023, according to PROCEPT BioRobotics Corporation, 5-year results from the WATER II Study showed that Aquablation therapy, a minimally invasive robotic surgical procedure for benign prostatic hyperplasia, safely and effectively relieved persistent symptoms in men with large prostates (80 to 150 mL) and maintains sexual function for up to five years. The study, which was released in the Journal of Urology, showed that patients' symptoms and quality of life kept improving significantly over time.

The key players are also involved in developing implants for the treatment of benign prostatic hyperplasia. The positive outcomes from the clinical studies have a positive impact on the market growth. For instance, as per the article published in Urology Times, the company ProVerum Limited invented the nitinol expander device for people with BPH in June 2022. The first treatment using the revolutionary ProVee System was successfully conducted in the key ProVIDE trial at Avant Concierge Urology. A self-expanding implant called ProVee gently reshapes and widens a restricted urethra to increase urine flow shortly after it is in place and also improves the quality of life in the patients. Thus, due to such advancements, the demand for Benign Prostatic Hyperplasia (BPH) treatment devices will increase in the near future.

Benign Prostatic Hyperplasia Treatment Devices Market Report Highlights:

  • Based on treatment, minimal invasive surgery dominated the BPH treatment devices market with a revenue share of 72.16 % in 2022, owing to the less postpartum pain and discomfort that may result from smaller incisions and less tissue manipulation
  • Based on procedure, Transurethral Resection of the Prostate (TURP) segment dominated the market in 2022 with a revenue share of 25.32%. The TURP procedure is considered a golden standard and the most effective BPH treatment
  • Based on end-use, hospitals held a majority share of the market with 64.77% in 2022. The increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for neurovascular catheters in the near future
  • North America led the market with the maximum revenue share of 34.95% in 2022. Rising demand for minimally invasive surgeries and rising government initiatives for improving healthcare infrastructures are among the key factors driving the market growth. In addition, technological advancement and innovation of new noninvasive techniques will create lucrative opportunities for the segment
Show more
Product Code: GVR-4-68040-119-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment
    • 1.1.2. Procedure
    • 1.1.3. Product
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. Product outlook
    • 2.2.4. End-use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Benign Prostatic Hyperplasia (BPH) Treatment Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Increasing prevalence of obesity and diabetes
      • 3.2.1.3. Shift towards minimally invasive prostatic procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of the treatment
      • 3.2.2.2. Strict government regulations
  • 3.3. Benign Prostatic Hyperplasia (BPH) Treatment Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Covid-19 Impact Analysis

Chapter 4. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Treatment Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Minimal Invasive Surgery
    • 4.1.2. Invasive Surgery
  • 4.2. Treatment Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market by Treatment Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 4.5.1. Minimal Invasive Surgery
      • 4.5.1.1. Minimal invasive surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Invasive Surgery
      • 4.5.2.1. Invasive surgery market estimates and forecast 2018 to 2030s, (USD Million)

Chapter 5. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Procedure Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Transurethral Microwave Thermotherapy
    • 5.1.2. Transurethral Needle Ablation of the Prostate
    • 5.1.3. Prostatic Urethral Lift
    • 5.1.4. Water Vapor Therapy
    • 5.1.5. Robot-Assisted Laparoscopic Prostatectomy
    • 5.1.6. Prostate Laser Surgery
    • 5.1.7. Aquablation Therapy
    • 5.1.8. Prostatic Artery Embolization
    • 5.1.9. Open Prostatectomy
    • 5.1.10. Transurethral Resection of the Prostate
    • 5.1.11. Bipolar Enucleation of Prostate
    • 5.1.12. Transurethral Incision of the Prostate
    • 5.1.13. High-Intensity Focused Ultrasound
  • 5.2. Procedure Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device Market by Procedure Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 5.5.1. Transurethral Microwave Thermotherapy
      • 5.5.1.1. Transurethral microwave thermotherapy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Transurethral Needle Ablation of the Prostate
      • 5.5.2.1. Transurethral needle ablation of the prostate market estimates and forecast 2018 to 2030 (USD Million
    • 5.5.3. Prostatic Urethral Lift
      • 5.5.3.1. Prostatic urethral lift market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Water Vapour Therapy
      • 5.5.4.1. Water vapour therapy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. Robot-Assisted Laparoscopic Prostatectomy
      • 5.5.5.1. Robot-assisted laparoscopic prostatectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.6. Prostate Laser Surgery
      • 5.5.6.1. Prostate laser surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.7. Aquablation Therapy
      • 5.5.7.1. Aquablation therapy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.8. Prostatic Artery Embolization
      • 5.5.8.1. Prostatic artery embolization market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.9. Open Prostatectomy
      • 5.5.9.1. Open prostatectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.10. Transurethral Resection of the Prostate
      • 5.5.10.1. Transurethral resection of the prostate market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.11. Bipolar Enucleation of Prostate
      • 5.5.11.1. Bipolar enucleation of prostate market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.12. Transurethral Incision of the Prostate
      • 5.5.12.1. Transurethral incision of the prostate market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.13. High-Intensity Focused Ultrasound
      • 5.5.13.1. High-intensity focused ultrasound market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Product Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Resectoscopes
    • 6.1.2. Urology Laser
    • 6.1.3. Radiofrequency Ablation
    • 6.1.4. Electrodes
    • 6.1.5. Catheter
    • 6.1.6. Prostatic Stents
    • 6.1.7. Implants
    • 6.1.8. Others
  • 6.2. Product Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device Market by Product Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Resectoscopes
      • 6.5.1.1. Resectoscopes market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Urology Laser
      • 6.5.2.1. Urology laser market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Radiofrequency Ablation
      • 6.5.3.1. Radiofrequency ablation market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Electrodes
      • 6.5.4.1. Electrodes market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Catheter
      • 6.5.5.1. Catheter market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Prostatic Stents
      • 6.5.6.1. Prostatic stents market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.7. Implants
      • 6.5.7.1. Implants market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.8. Others
      • 6.5.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: End-use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
    • 7.1.1. Hospitals
    • 7.1.2. Specialty Facilities
    • 7.1.3. Research and Academic Institute
  • 7.2. End-use Market Share, 2018 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device by End-use Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Hospitals
      • 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Specialty facilities
      • 7.5.2.1. Specialty facilities market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Research and Academic Institute
      • 7.5.3.1. Research and academic institute market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2018 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2022
    • 9.3.4. Karl Storz
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Boston Scientific Corporation
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Olympus America
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Endo Pharmaceuticals Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Biolitec AG
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Medifocus
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Cook Medical
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Teleflex Incorporated
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Urotronic
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Coloplast Corp
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Richard Wolf GmbH
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. PROCEPT BioRobotics Corporation
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Product benchmarking
      • 9.3.15.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-119-1

List of Tables

  • Table 1. List of regulatory bodies for different countries
  • Table 2. Key companies' product launches
  • Table 3. Key companies' mergers and acquisitions
  • Table 4. Key companies' collaboration
  • Table 5. Other strategic initiatives of companies
  • Table 6. North America benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 8. North America benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 9. North America benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 10. North America benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 11. U.S. benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 12. U.S. benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 13. U.S. benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 14. U.S. benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 15. Canada benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 16. Canada benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 17. Canada benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 18. Canada benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 19. Europe benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 21. Europe benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 22. Europe benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 23. Europe benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 24. UK benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 25. UK benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 26. UK benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 27. UK benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 28. Germany benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 29. Germany benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 30. Germany benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 31. Germany benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 32. France benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 33. France benign prostatic hyperplasia (BPH) treatment device market, by Procedure, 2018 - 2030 (USD Million)
  • Table 34. France benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 35. France benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 36. Italy benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 37. Italy benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 38. Italy benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 39. Italy benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 40. Spain benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 41. Spain benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 42. Spain benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 43. Spain benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 44. Norway benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 45. Norway benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 46. Norway benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 47. Norway benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 48. Sweden benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 49. Sweden benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 50. Sweden benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 51. Sweden benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 52. Denmark benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 53. Denmark benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 54. Denmark benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 55. Denmark benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 57. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 58. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 59. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 60. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 61. Japan benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 62. Japan benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 63. Japan benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 64. Japan benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 65. China benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 66. China benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 67. China benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 68. China benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 69. India benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 70. India benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 71. India benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 72. India benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 73. Australia benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 74. Australia benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 75. Australia benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 76. Australia benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 77. South Korea benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 78. South Korea benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 79. South Korea benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 80. South Korea benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 81. Thailand benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 82. Thailand benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 83. Thailand benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 84. Thailand benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 85. Latin America benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 86. Latin America benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 87. Latin America benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 88. Latin America benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 89. Latin America benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 90. Brazil benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 91. Brazil benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 92. Brazil benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 93. Brazil benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 94. Mexico benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 95. Mexico benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 96. Mexico benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 97. Mexico benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 98. Argentina benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 99. Argentina benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 100. Argentina benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 101. Argentina benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 102. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 103. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 107. South Africa benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 108. South Africa benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 109. South Africa benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 110. South Africa benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 111. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 112. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 115. UAE benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 116. UAE benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 117. UAE benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 118. UAE benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 119. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 120. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 121. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 122. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Benign prostatic hyperplasia (BPH) treatment device market segmentation
  • Fig 2. Market research process
  • Fig 3. Information procurement process
  • Fig 4. Primary research pattern
  • Fig 5. Benign prostatic hyperplasia (BPH) treatment device market snapshot, 2022 (USD Million)
  • Fig 6. Segment snapshot, USD Million
  • Fig 7. Competitive landscape snapshot
  • Fig 8. Penetration & growth prospect mapping, by product
  • Fig 9. Market driver analysis (Current & future impact)
  • Fig 10. Market restraint analysis (Current & future impact)
  • Fig 11. Benign prostatic hyperplasia (BPH) treatment device market, Treatment outlook key takeaways (USD Million)
  • Fig 12. Benign prostatic hyperplasia (BPH) treatment device market: Treatment movement analysis (USD Million), 2022 & 2030
  • Fig 13. Minimal invasive surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 14. Invasive surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 15. Benign prostatic hyperplasia (BPH) treatment device market, Procedure outlook key takeaways (USD Million)
  • Fig 16. Benign prostatic hyperplasia (BPH) treatment device market: Procedure movement analysis (USD Million), 2022 & 2030
  • Fig 17. Transurethral microwave thermotherapy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 18. Transurethral needle ablation of the prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 19. Prostatic urethral lift market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 20. Water vapour therapy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 21. Robot-assisted laparoscopic prostatectomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 22. Prostate laser surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 23. Aquablation therapy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 24. Prostatic artery embolization market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 25. Open prostatectomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. Transurethral resection of the prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Bipolar enucleation of prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Transurethral incision of the prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 29. High-intensity focused ultrasound market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 30. Benign prostatic hyperplasia (BPH) treatment device market, Product outlook key takeaways (USD Million)
  • Fig 31. Benign prostatic hyperplasia (BPH) treatment device market: Product movement analysis (USD Million), 2022 & 2030
  • Fig 32. Resectoscopes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 33. Urology laser market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 34. Radiofrequency ablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 35. Electrodes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 36. Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. Prostatic stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. Implants market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. Benign prostatic hyperplasia (BPH) treatment device market, End-use outlook key takeaways (USD Million)
  • Fig 41. Benign prostatic hyperplasia (BPH) treatment device market: End-use movement analysis (USD Million), 2022 & 2030
  • Fig 42. Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. Specialty facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 44. Research and manufacturing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 45. Benign prostatic hyperplasia (BPH) treatment device market: Regional key takeaways (USD Million)
  • Fig 46. Benign prostatic hyperplasia (BPH) treatment device market: Regional outlook, 2022 & 2030, USD Million
  • Fig 47. North America benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 48. U.S. benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 49. Canada benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 50. Europe benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 51. UK benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 52. Germany benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 53. France benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 54. Spain benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 55. Italy benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 56. Sweden benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 57. Norway benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 58. Denmark benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 59. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 60. China benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 61. Japan benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 62. India benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 63. South Korea benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 64. Australia benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 65. Thailand benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 66. Latin America benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 67. Brazil benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 68. Mexico benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 69. Argentina benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 70. Middle East and Africa benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 71. South Africa benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 72. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 73. UAE benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 74. Kuwait benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 75. List of key emerging companies/procedure disruptors/innovators
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!